苯甲酰胺
化学
酰胺
取代基
对接(动物)
立体化学
戒指(化学)
组蛋白脱乙酰基酶
杂原子
MTT法
苯并咪唑
细胞生长
组合化学
生物化学
组蛋白
DNA
有机化学
护理部
医学
作者
Taiping Chen,Hongwu Jiang,Jianjun Zhou,Zicheng Li,Wencai Huang,Youfu Luo,Yinglan Zhao
出处
期刊:Medicinal Chemistry
[Bentham Science Publishers]
日期:2019-07-16
卷期号:16 (4): 555-562
被引量:8
标识
DOI:10.2174/1573406415666190712120611
摘要
Background: Histone deacetylases inhibitors (HDACIs) with different chemical structures have been reported to play an important role in the treatment of cancer. Objective: The study aims to modify the structure of Entinostat (MS-275) to discover new compounds with improved anti-proliferative activities and perform SAR studies on this class of bioactive compounds. Methods: Fourteen N-substituted benzamide derivatives were synthesized and their antiproliferative activities were tested with four cancer cell lines (MCF-7, A549, K562 and MDA-MB- 231) by MTT assay. Results: Compared with MS-275, six compounds exhibited comparable or even better antiproliferative activities against specific/certain cancer cell lines. Conclusion: The preliminary SARs showed that (ⅰ) the 2-substituent of the phenyl ring in the R group and heteroatoms of amide which can chelate with zinc ion are critical to the antiproliferative activity and (ⅱ) chlorine atom or nitro-group on the same benzene ring largely decreases their anti-proliferative activity. Molecular docking study illustrated the interaction (binding affinity) between the synthesized compounds and HDAC2 was observed to be similar to that of MS-275.
科研通智能强力驱动
Strongly Powered by AbleSci AI